Stephan started his professional career as the co-founder and Member of the Executive Board of TERAKLIN, a medical device business which focused on implementing a new liver support therapy (MARS). The company was later acquired by Gambro in 2004, where he took on the role of VP R&D Portfolio & Marketing for the Acute Therapies Business Unit.

In 2014, Stephan joined Baxter International Inc. as Director Therapy Marketing Acute Renal for the EMEA region and was responsible for the strategic marketing and new product launches.

Stephan, who has a PhD in Chemistry, is very excited to be part of the ADVITOS family. “I’m thrilled about the new options of the ADVOS therapy and this new approach which can significantly improve the therapy outcomes of critically ill patients. Now that ADVITOS has already achieved success on the German market, I am particularly looking forward to the extremely exciting challenge of establishing the therapy in other markets.”

When Stephan is not pursuing his passion to connect science and innovation with marketing and strategy, he is enjoying heavy metal concerts and doing some DIY work on his house extension.